Is Chengdu Olymvax Biopharmaceuticals Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Chengdu Olymvax Biopharmaceuticals Inc (688319.SS) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Chengdu Olymvax Biopharmaceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Chengdu Olymvax Biopharmaceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Chengdu Olymvax Biopharmaceuticals Inc?

Muslim investors may consider investing in Chengdu Olymvax Biopharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Chengdu Olymvax Biopharmaceuticals Inc classified as NOT COVERED?

Musaffa determines the Shariah status of Chengdu Olymvax Biopharmaceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Chengdu Olymvax Biopharmaceuticals Inc updated?

The Shariah compliance status of Chengdu Olymvax Biopharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Chengdu Olymvax Biopharmaceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Chengdu Olymvax Biopharmaceuticals Inc?

You can check the latest Shariah compliance status of Chengdu Olymvax Biopharmaceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Chengdu Olymvax Biopharmaceuticals Inc 688319.SS

Last Updated: May 15, 12:00 AM·SSE

Chengdu Olymvax Biopharmaceuticals Inc. Stock Analysis 688319.SS

China Health Care Small Cap

Chengdu Olymvax Biopharmaceuticals, Inc. engages in the research, development, manufacture, and sale of vaccines. The company is headquartered in Chengdu, Sichuan and currently employs 451 full-time employees. The company went IPO on 2021-06-08. The firm's products mainly include adsorbed tetanus vaccine, Haemophilus influenzae type b conjugate vaccine, Group A and Group C meningococcal polysaccharide conjugate vaccine, and refined tetanus toxoid concentrate. The firm's main customers are center for disease control and prevention customers. The firm mainly conducts its businesses in the domestic market.

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.

I accept the above